Merck to Acquire Cidara for $9.2 Billion, Focusing on Influenza Prevention
Merck announced on Friday that it is acquiring Cidara Therapeutics for $9.2 billion, a strategic…
Newswire
Merck to Acquire Cidara for $9.2 Billion, Expanding Flu Prevention Pipeline
Merck announced on Friday its intention to acquire Cidara Therapeutics, a company focused on developing…
Eli Lilly and Novo Nordisk Disown Mangoceuticals’ GLP-1RA Partnership Claim
Eli Lilly and Novo Nordisk have officially refuted claims made by Mangoceuticals regarding a purported…
Mikael Dolsten Withdraws Board Candidacy at Novo Nordisk Amid Leadership Changes
In a significant development for Novo Nordisk, former Pfizer Chief Scientific Officer Mikael Dolsten has…
Otsuka’s HAE med Dawnzera, Lilly’s oral SERD Inluriyo among drugs scoring EU endorsements
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has granted endorsements…
Medicxi Secures €500 Million for New Biotech Fund to Transform Patient Care
London-based VC firm Medicxi has successfully closed a new fund totaling €500 million ($581 million),…
Kura and Kyowa Kirin secure FDA go-ahead for targeted leukaemia therapy
Kura Oncology and Kyowa Kirin have received FDA approval for Komzifti, marking it as the…
CHMP Recommends Ten New Medicines for Approval at November 2025 Meeting
At its November 2025 meeting, the Committee for Medicinal Products for Human Use (CHMP) recommended…
LB Pharmaceuticals, Celldex Hire Commercial Chiefs as Launch Plans Ramp Up
LB Pharmaceuticals and Celldex have separately stepped up their respective launch preparations by appointing new…
Organon and Henlius’ Poherdy, first biosimilar to Roche’s Perjeta, scores FDA nod
The FDA has granted approval to Organon and Henlius Biotech’s Poherdy, marking it as the…